X4 Pharmaceuticals Statistics
Total Valuation
XFOR has a market cap or net worth of $33.20 million. The enterprise value is $48.50 million.
Important Dates
The last earnings date was Friday, August 8, 2025, before market open.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XFOR has 11.41 million shares outstanding. The number of shares has increased by 4.04% in one year.
| Current Share Class | 11.41M |
| Shares Outstanding | 11.41M |
| Shares Change (YoY) | +4.04% |
| Shares Change (QoQ) | +7.92% |
| Owned by Insiders (%) | 3.16% |
| Owned by Institutions (%) | 29.60% |
| Float | 11.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.62 |
| Forward PS | 2.74 |
| PB Ratio | 5.87 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.19, with a Debt / Equity ratio of 19.65.
| Current Ratio | 3.19 |
| Quick Ratio | 2.83 |
| Debt / Equity | 19.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.57 |
Financial Efficiency
Return on equity (ROE) is -207.22% and return on invested capital (ROIC) is -51.97%.
| Return on Equity (ROE) | -207.22% |
| Return on Assets (ROA) | -41.92% |
| Return on Invested Capital (ROIC) | -51.97% |
| Return on Capital Employed (ROCE) | -128.71% |
| Revenue Per Employee | $229,189 |
| Profits Per Employee | -$713,119 |
| Employee Count | 143 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 2.78 |
Taxes
In the past 12 months, XFOR has paid $344,000 in taxes.
| Income Tax | 344,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -84.52% in the last 52 weeks. The beta is 0.60, so XFOR's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -84.52% |
| 50-Day Moving Average | 2.16 |
| 200-Day Moving Average | 9.31 |
| Relative Strength Index (RSI) | 67.66 |
| Average Volume (20 Days) | 10,500,840 |
Short Selling Information
The latest short interest is 1.02 million, so 8.95% of the outstanding shares have been sold short.
| Short Interest | 1.02M |
| Short Previous Month | 390,377 |
| Short % of Shares Out | 8.95% |
| Short % of Float | 9.25% |
| Short Ratio (days to cover) | 0.61 |
Income Statement
In the last 12 months, XFOR had revenue of $32.77 million and -$101.98 million in losses. Loss per share was -$14.76.
| Revenue | 32.77M |
| Gross Profit | 27.20M |
| Operating Income | -105.89M |
| Pretax Income | 17.73M |
| Net Income | -101.98M |
| EBITDA | -104.52M |
| EBIT | -105.89M |
| Loss Per Share | -$14.76 |
Full Income StatementBalance Sheet
The company has $62.95 million in cash and $78.02 million in debt, giving a net cash position of -$15.07 million or -$1.32 per share.
| Cash & Cash Equivalents | 62.95M |
| Total Debt | 78.02M |
| Net Cash | -15.07M |
| Net Cash Per Share | -$1.32 |
| Equity (Book Value) | 3.97M |
| Book Value Per Share | 0.50 |
| Working Capital | 50.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$109.30 million and capital expenditures -$133,000, giving a free cash flow of -$109.43 million.
| Operating Cash Flow | -109.30M |
| Capital Expenditures | -133,000 |
| Free Cash Flow | -109.43M |
| FCF Per Share | -$9.59 |
Full Cash Flow StatementMargins
| Gross Margin | 83.00% |
| Operating Margin | -323.09% |
| Pretax Margin | -310.10% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
XFOR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.04% |
| Shareholder Yield | n/a |
| Earnings Yield | -305.08% |
| FCF Yield | -327.37% |
Analyst Forecast
The average price target for XFOR is $71.17, which is 2,345.70% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $71.17 |
| Price Target Difference | 2,345.70% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 139.01% |
| EPS Growth Forecast (5Y) | -23.13% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 28, 2025. It was a reverse split with a ratio of 1:30.
| Last Split Date | Apr 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
XFOR has an Altman Z-Score of -9.18 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.18 |
| Piotroski F-Score | 2 |